Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Life Sciences Bpo Market

Published Date : Jun 2020

Life Sciences BPO market comprises of contracting of non-primary business activities and functions to a third-party provider. The global life sciences BPO market is driven by factors such as increasing cost of research and development (R&D), growing price pressure... View more

Coherent Market Insights Anastrozole Tablets Market

Published Date : May 2020

Anastrozole tablets are used for the treatment of postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer after surgery or postmenopausal women diagnosed with advanced-stage or metastatic hormone-receptor-positive breast cancer. Anastr... View more

Coherent Market Insights Non Small Cell Lung Cancer Market

Published Date : Feb 2020

Lung cancer symptoms are not noticeable in its early stage as these symptoms are considered for other type of illness such as pneumonia or collapsed lung. Some symptoms of lung cancer include chest pain, harsh/raspy sound while breathing, wheezing, weight loss, contin... View more

Coherent Market Insights Brazil Enteral Nutrition Market

Published Date : Feb 2020

Enteral nutrition refers to delivery of food containing carbohydrates, proteins, water, fat, minerals, and vitamins in the body through the gastrointestinal tract with the help of feeding tubes. It is imperative for patients to have a functional gastrointestinal tract... View more

Coherent Market Insights Empty Capsules Market

Published Date : Feb 2020

Empty capsules are manufacture red from gelatin, and is used for drug products constituting of dry, powdered ingredients or miniature pellets, semi-solids, and liquids. Raw material required for manufacturing of empty capsules consists of Type-A(Pork Skin), Type-B Gel... View more

Coherent Market Insights Parenteral Packaging Market

Published Date : Feb 2020

Parenteral packaging is the process of packaging injectables or parenteral solutions to keep their therapeutic effectiveness intact till the point of administration. Parental packaging is required to protect the drugs from contamination and to ensure aseptic administr... View more

Coherent Market Insights First Aid Kit Market

Published Date : Feb 2020

First aid kits are used in homes, schools, offices, vehicles, recreational centers, and gyms to manage unexpected injuries. These are one of the most commonly used medical accessories in home care settings along with public and private healthcare facilities. A first a... View more

Coherent Market Insights Epistaxis Market

Published Date : Jan 2020

Epistaxis, also known as nose bleeding, is a common clinical condition that results in loss of blood from the tissue lining of the nose. Epistaxis is usually classified as anterior or posterior epistaxis. Anterior epistaxis is defined as the bleeding from anterior sep... View more

Coherent Market Insights Generic Oncology Sterile Injectables Market

Published Date : Jan 2020

Generic oncology sterile injectables are used for the treatment of various types of cancers such as ovarian, breast, and lung. Generic oncology sterile injectables products are relatively cheaper than branded counterparts. Treatment cost is a major concern for cancer ... View more

Coherent Market Insights Cold Cough And Sore Throat Remedies Market

Published Date : Jan 2020

Cold, cough, and sore throat are common infections occurring due to different viruses and can be easily treated with various medications such as antihistamines, expectorants, bronchodilators, decongestants, and others. Increasing prevalence of viral infections causing... View more

Coherent Market Insights Sexual Health Market

Published Date : Jan 2020

Sexual health is an important part of a person’s physical and mental health. Sexual health leads to the healthy sexual life without any sexual dysfunctions, and preventive measures to avoid sexually transm... View more

Coherent Market Insights Facial Injectables Market

Published Date : Dec 2019

Facial injectables, are also called as facial fillers, and are used in aesthetic therapeutic procedures to enhance facial appearance. Facial injectables are used for smoothening wrinkles and scars on the face by filling the target area. Dermal fillers reduce wrinkles ... View more

Coherent Market Insights Us Unfractionated Heparin Market

Published Date : Dec 2019

Unfractionated heparin (UFH) is a natural protein in human body which supports to thin the blood by combining with antithrombin.  Unfractionated heparin binds to antithrombin, which enhances the ability of inhibiting the most potential clotting factors in the bod... View more

Coherent Market Insights Autism Spectrum Disorder Therapeutics Market

Published Date : Dec 2019

Autism, scientifically referred as Autism Spectrum Disorder Therapeutics (ASD) is a complex neurological disorder that is characterized by symptoms including challenges with social skills, repetitive behaviours, as well as issues with speech and non-verbal communicati... View more

Coherent Market Insights Dermatophytic Onychomycosis Treatment Market

Published Date : Dec 2019

Nail onychomycosis is a fungal infection is caused by a trichophyton rubrum, trichophyton mentagrophytes, and in some cases it is caused by yeasts and molds. The major factors responsible for nail onchomycosis infection is increased exposure to worm and moist environm... View more

Coherent Market Insights Cytotoxic Drugs Contract Manufacturing Market

Published Date : Dec 2019

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost... View more

Coherent Market Insights Middle East And Turkey Immune Thrombocytopenic Purpura Treatment Drugs Market

Published Date : Dec 2019

Two therapies are used for treatment of ITP in Middle East, and it is categorized into first-line therapy (Corticosteroids, intravenous immunoglobulin (IVIG), and anti-D immune globulin) and second-line therapy (thrombopoietin receptor agonists, monoclonal antibody). ... View more

Coherent Market Insights Saline Laxatives Market

Published Date : Dec 2019

Saline laxatives are soluble inorganic salts that contain multivalent cations or anions. Examples of saline laxatives include citrate salts (Royvac), magnesium preparations (Phillips’ Milk of Magnesia), sulfate salts, and sodium phosphate. Saline laxatives can b... View more

Coherent Market Insights Us Cannabis Testing Service Market

Published Date : Dec 2019

US Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purposes. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal b... View more

Coherent Market Insights Netherlands Compounding Pharmacies Market

Published Date : Dec 2019

Compounding pharmacies constitutes of compounding of pharmaceutical products tailor made in accordance with the needs of the patient. Compounding pharmacies is a type of personalized medicine and caters to specific needs of the patients. Increasing government initiati... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.